Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

• Daniel B. Reeves,
• Bryan T. Mayer,
• Allan C. deCamp,
• Yunda Huang,
• Bo Zhang,
• Lindsay N. Carpp,
• Craig A. Magaret,
• Michal Juraska,
• Peter B. Gilbert,
• David C. Montefiori,
• Katharine J. Bar,
• E. Fabian Cardozo-Ojeda,
• Joshua T. Schiffer,
• Raabya Rossenkhan,
• Paul Edlefsen,
• Lynn Morris,
• Nonhlanhla N. Mkhize,
• Carolyn Williamson,
• James I. Mullins,
• Kelly E. Seaton,
• Georgia D. Tomaras,
• Philip Andrew,
• Nyaradzo Mgodi,
• Julie E. Ledgerwood,
• Myron S. Cohen,
• Lawrence Corey,
• Logashvari Naidoo,
• Catherine Orrell,
• Paul A. Goepfert,
• Martin Casapia,
• Magdalena E. Sobieszczyk,
• Shelly T. Karuna,
• Srilatha Edupuganti

Affiliations

Daniel B. Reeves

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Bryan T. Mayer

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Allan C. deCamp

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Yunda Huang

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Bo Zhang

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Lindsay N. Carpp

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Craig A. Magaret

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Michal Juraska

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Peter B. Gilbert

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

David C. Montefiori

Department of Surgery, Duke University Medical Center

Katharine J. Bar

Perelman School of Medicine, University of Pennsylvania

E. Fabian Cardozo-Ojeda

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Joshua T. Schiffer

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Raabya Rossenkhan

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Paul Edlefsen

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Lynn Morris

National Institute for Communicable Diseases, National Health Laboratory Service

Nonhlanhla N. Mkhize

National Institute for Communicable Diseases, National Health Laboratory Service

Carolyn Williamson

Division of Medical Virology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service

James I. Mullins

Department of Global Health, University of Washington

Kelly E. Seaton

Center for Human Systems Immunology, Duke University

Georgia D. Tomaras

Center for Human Systems Immunology, Duke University

Philip Andrew

Family Health International

Nyaradzo Mgodi

Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences

Julie E. Ledgerwood

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Myron S. Cohen

Institute for Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill

Lawrence Corey

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Logashvari Naidoo

South African Medical Research Council, HPRU

Catherine Orrell

Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town

Paul A. Goepfert

Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham

Martin Casapia

Facultad de Medicina Humana, Universidad Nacional de la Amazonia Peru

Magdalena E. Sobieszczyk

Division of Infectious Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons, New York-Presbyterian/Columbia University Irving Medical Center

Shelly T. Karuna

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center

Srilatha Edupuganti

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine